Biotek-snakken — Marts 2021
-
Spændende ny CEO hos Orphazyme - kommer som direktør for Amgens kræft division og har stået for kommencialisering af adskillige
produkter -
+7%
-
Fandel...ny all time high i XBrane kurs
106...det går da meget godt -
Press ReleaseCopenhagen, March01, 20212cureX announces that the clinicaltrial of IndiTreat
-guided treatment of metastatic colorectal cancer has met the primary endpoint.2cureX announced todaythat its prospective interventional clinical trial investigating the benefit of IndiTreat-guided treatment achieved its primary endpoint by improvingProgression Free Survival (PFS) after eight weeks of treatment. Full data has been submitted to the American Society of Clinical Oncology (ASCO) 2021 . -
-
Orphazyme..
-
Enig og ja mht datoen
-
Forventer at den vil gå mod kurs 100 op imod datoen - folk vil spekulere i afgørelsen - der efter er det plat/krone. På godkendt 150. uden....
-
Men meget svært, enig
-
Velbekomme - spændende i den!
-
Og er også selv med - netto på 75
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind